Endovascular treatment of subdural hematoma in patient under anti-platelet therapy : a case report

Author:

Thapa Parash1,Bhattarai Ganesh2,Kharel Santosh Kumar2,Kunwar Pratiksha3,Bhandari Sagar4,Bhandari Shailaj5,Silapkar Sushil6,Thapa Bikash6,Thapa Ajit1,Sharma Mohan Raj6

Affiliation:

1. Department of Radiology, Maharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Maharajgunj, 44600, Nepal

2. Maharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Maharajgunj, 44600, Nepal

3. College of Medical Science,Bharatpur,44207,Nepal

4. National Medical College,Birgunj,44500,Nepal

5. Nepal Medical College Teaching Hospital,Jorpati,Katmandu,44600,Nepal

6. Department of Neurosurgery, Maharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Maharajgunj, 44600, Nepal

Abstract

Introduction: The incidence of chronic subdural hematoma (cSDH) is relatively high among the elderly population. Other known risk factors for cSDH include male gender, dependency on antiplatelet or anticoagulant medication, and chronic alcoholism. Although, the standard mode of treatment for cSDH is surgery, embolization of the middle meningeal artery (MMA), either upfront or as an adjunct to surgical evacuation can be used for the treatment of cSDH. Case presentation: We present a case of a 75-year-old female with prior history of posterior -lateral wall myocardial infarction (MI) eight years back presented to our center with the chief complaints of a gradual onset of cough and headache for 2 months. The patient had no history of trauma, loss of consciousness, seizures, and vomiting. There was no history of diabetes, hypertension, pulmonary tuberculosis, and other chronic illness. Discussion: The concurrent use of anti- platelet drug during a surgical procedure can make the treatment challenging. Endovascular treatment can be a primary treatment modality in such situation. Conclusion: Elimination of blood supply by middle meningeal artery embolization is emerging as a safe, minimally invasive alternative to treat cSDH.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3